MINICUCCI, LAURA
 Distribuzione geografica
Continente #
EU - Europa 5.596
Totale 5.596
Nazione #
IT - Italia 5.596
Totale 5.596
Città #
Genova 4.300
Rapallo 802
Genoa 470
Bordighera 24
Totale 5.596
Nome #
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients 154
Phenotype/Genotype Correlation and Cystic Fibrosis Related Diabetes Mellitus (Italian Multicenter Study) 150
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients 144
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. 139
Impact of inhaled corticosteroids on the risk of early Pseudomonas Aeruginosa acquisition in cystic fibrosis 134
Younger age at diagnosis of Type 1 diabetes mellitus in children of immigrated families born in Italy. 132
Pathological role of the calpain/calpastatin system in cystic fibrosis 128
Home nebulizer use and bacterial colonization in cystic fibrosis. 124
Diabetes mellitus after kidney transplantation in pediatric recipients 123
Caregiver burden and vocational participation among parents of adolescents with CF 121
Validation of a predictive survival model in Italian patients with cystic fibrosis 120
Discharge report accuracy 119
Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an italian Cystic Fibrosis Center 117
Blood Ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study) 116
High incidence of childhood type 1 diabetes in Liguria, Italy, from 1989 to 1998 114
Discrepancy between sensitization to inhaled allergens and respiratory symptoms in pediatric patients with type 1 diabetes mellitus. 114
Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR 110
FùPhenotype-genotype correlation and cystic fibrosis related diabetes (CFRD) 109
The calpain-calpastatin system in cystic fibrosis: physiopathological implications 109
Antimicrobial use and Pseudomonas Aeruginosa susceptibility profile in a cystic fibrosis centre 107
Vitamin D receptor polymorphisms: are they really associated with type 1 diabetes? 106
N1303K MUTATION AND DIABETES MELLITUS IN CYSTIC FIBROSIS. 104
Alcaligenes xylosoxidans ed evoluzione della lesione polmonare in fibrosi cistica. 102
Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project). 102
Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). 100
Oxidative stress and antioxidant therapy in cystic fibrosis. 100
Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial. 93
Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results. 92
Alta incidenza di diabete di tipo 1 in Liguria nel periodo 1989-1998 91
Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. 91
Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience. 90
Role of home therapy with ofloxacin in patients with cystic fibrosis (CF) 89
Beclometasone dipropionato per aerosol versus budesonide per turbohaler nella broncopneumopatia della fibrosi cistica. 89
Oral hypoglycemic agents in Cystic Fibrosis related diabetes (CFRD) 85
Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis 82
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients Clin Chem Lab Med. 2011 Jan;49(1):49-54. 81
Liver disease as risk factor for cystic fibrosis-related diabetes development 80
Programmi svolti dalla II Clinica Pediatrica. 70
Cystic Fibrosis - Related diabetes mellitus 69
When should hyperglycemia be treated in cystic fibrosis? 68
Ursodeoxycholic Acid for Liver Disease Associated with Cystic Fibrosis: A Double-Rlind Multifiter Trial 67
Identification of novel WFS1 mutations in Italian children with Wolfram Syndrome 67
The use of ofloxacin in cystic fibrosis patients. 64
Terapia cortisteroidea inalatoria nella broncopneumopatia della fibrosi cistica: confronto tra beclometasone dipropionato per aerosol e budesonide per turbohaler. 62
Elevata incidenza del diabete mellito di tipo 1 in Liguria dal 1989 al 1998 62
Nuove mutazioni del gene della wolframina in tre casi pediatrici 61
Marker immunologici di diabete di tipo 1 in fibrosi cistica. 60
The significance of 2-thiol-propionamido-acetic acid in the treatment of cystic fibrosis. 59
Identificazione di neonati a rischio genetico di diabete tipo 1 (DM1) da avviare a prevenzione primaria (studio PREVEFIN) - Dati preliminari 59
Screening for type 1 diabetes genetic rIsk in newborns of continental Italy. Primary prevention (Prevefin Italy) - preliminary data 59
Characterization of Staphylococcus aureus small colony variant strains isolated from Italian patients attending a regional cystic fibrosis care centre. 59
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 59
Emergenze diabetologiche: chetoacidosi diabetica 58
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. 58
Prima descrizione italiana di una nuova mutazione nel gene HNF-1beta (MODY 5) 57
Ruolo di alcaligenes xylodoxidans nella broncopneumopatia cronica in fibrosi cistica. 55
”Punteggi di valutazione clinica nella Fibrosi Cistica”. 54
The adolescent with type 1 diabetes mellitus. 53
Study of efficacy of piperacillin in the treatment of severe infections of the child and of the young adult 52
Usefulness of blood ketone bodies for monitoring insulin therapy in patients with recent onset type 1 diabetes (a multicenter study). 51
Il Diabete in Fibrosi cistica 50
Indagini per le funzioni epatobiliari 44
MODY e diabete non autoimmune. 43
Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate 37
Totale 5.618
Categoria #
all - tutte 12.543
article - articoli 9.203
book - libri 0
conference - conferenze 2.854
curatela - curatele 0
other - altro 115
patent - brevetti 0
selected - selezionate 0
volume - volumi 371
Totale 25.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019304 0 0 0 0 0 0 0 0 4 52 148 100
2019/20201.641 51 44 81 80 136 177 328 75 120 281 205 63
2020/2021314 18 41 9 24 14 30 18 29 32 30 25 44
2021/2022729 9 49 55 104 20 43 56 195 18 66 21 93
2022/2023941 76 63 11 136 118 177 2 116 147 12 77 6
2023/2024355 27 55 4 58 43 114 4 33 17 0 0 0
Totale 5.618